dokumendiregister.ee
OtsingAsutusedMCP
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel
Otsing›Ravimiamet
Sissetulev kiriAvalik

Euroopa farmakopöa töökava asjus

Ravimiamet · 5. märts 2025
Viit
REP-1/1204-1
Registreeritud
5. märts 2025
Dokumendi liik
Sissetulev kiri
Adressaat
European Directorate for the Quality of Medicines & HealthCare
Saabumis/saatmisviis
e-post
Funktsioon
REP Euroopa Farmakopöaga seotud asjaajamine
Sari
REP-1 Euroopa Farmakopöa alane kirjavahetus
Toimik
REP-1/2025
Vastutaja
Signe Leito (RA, Peadirektori asetäitja valdkond, Labor)

Failid

  • 📎WP_Addition_Pseudoephedrine sulfate_RZ_PH_2025-00742L_ekiri.pdf664 KB

Sisu (failidest)

Signe Leito Saatja: [email protected] Saatmisaeg: kolmapäev, 19. veebruar 2025 10:06 Adressaat: Signe Leito Teema: Proposal to add a new monograph on Pseudoephedrine sulfate to the Ph. Eur. work programme of Group 10A: EDQM-2025-00771-mail Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Please make sure to include in any reply our mail reference: EDQM-2025-00771-mail **************************************************************************** European Pharmacopoeia Commission Secretariat RZ/PH/ 2025-00742L Strasbourg, 18/02/2025 JSB/ mk LETTER FOR THE ATTENTION OF THE NPAs Copy: Presidium Dear Colleagues, Please find below the link to a survey being carried out concerning the proposed addition of the monograph Pseudoephedrine sulfate to the work programme of Group 10A. In order to have access to the survey, please copy and paste this link into your Internet browser: https://survey.edqm.eu/index.php?r=survey/index&sid=814918&lang=en Deadline for replies: 13 March 2025 With kind regards, 1 On behalf of Dr Jaume SANZ-BISET Mireille KOPF Assistant - European Pharmacopoeia Department EDQM - Council of Europe 7 Allée Kastner Cs-30026 F-67081 Strasbourg France Tel. : +33 (0)3 88 41 28 53 [email protected] www.edqm.eu **************************************************************************** Please make sure to include in any reply our mail reference: EDQM-2025-00771-mail 2
Allikas: Ravimiamet dokumendiregister →